Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Completed · Phase 3

Conditions studied: Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Injecting allovectin-7 into a person's melanoma cells may make the body build an immune response that will kill tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or without immunotherapy in treating patients who have stage III or stage IV melanoma.

Key facts

Study ID
NCT00003647
Run by
Vical
Starts
1998-07-01
Expected to finish
2002-09-01
Last updated by the study team
2008-07-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.